PROGNOSIS FACTORS AND TREATMENT TACTICS OF PATIENTS WITH UTERINE LEIOMYOSARCOMA

Cover Page

Cite item

Full Text

Abstract

Surgery is the main method of treatment of the patients with the uterine leiomyosarcoma. A standard extent of surgery is extirpation of the uterus without its appendages in the reproductive period or with uterine appendages in the postmenopause. The comparative analysis of the remote results of the treatment of the patients depending on the radicality of the performed surgery let to find out that the presence of the resid- ual tumor in the minor pelvis significantly worsens the course and the prognosis of the disease in the patients with the uterine leiomyosarco- ma. The adjuvant therapy is worth using for the prophylaxis of the distant metastasizing in the patients with the uterine leiomyosarcoma in the presence the poor prognosis factors. The postoperative radiotherapy of the patients is ineffective due to the low radio sensitivity of the tumor. The poor prognosis factors are: postmenopause, age over 60 years, the presence of the residual tumor, invasion depth more than half of the myometrium, invasion of the tumor up to the tunica serosa uteri, tumor size more than 5 cm, tumor necroses, low grade of the tumor differ- entiation, mitoses rate more than 10 in 10 view fields. The vital prognosis of the patients with the distant metastases depends on their charac- ter. In case of solitary metastases — the prognosis is favorable, in patients with the multiple metastases the prognosis worsens essentially.

About the authors

I. R. Gagua

Scientific and Research Institute of Clinical Oncology of N.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences

Author for correspondence.
Russian Federation

V. V. Kuznetzov

Scientific and Research Institute of Clinical Oncology of N.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences

Russian Federation

N. I. Lazareva

Scientific and Research Institute of Clinical Oncology of N.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences

Russian Federation

V. M. Nechushkina

Scientific and Research Institute of Clinical Oncology of N.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences

Russian Federation

T. I. Zakharova

Scientific and Research Institute of Clinical Oncology of N.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences

Russian Federation

Zh. A. Zavolskaya

Scientific and Research Institute of Clinical Oncology of N.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2008



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36991 от  21.07.2009.